Image

Strengthening Families Living With HIV in Kenya

Recruiting
13 years of age
Both
Phase N/A

Powered by AI

Overview

This study seeks to use a group-based microfinance/internal lending model to develop social capital among people with HIV in Kenya. This will create a context to deliver validated curriculum targeting intimate partner violence, positive parenting, agriculture, small business entrepreneurship, group-interpersonal therapy, and other determinants of well-being and ART adherence among people with HIV. The primary outcomes are viral suppression, ART adherence, and common mental disorders.

Description

It is anticipated that involvement in an internal savings and lending program will create social capital among people with HIV and their guardians (in case of adolescents w HIV). This social capital accrual will be leveraged to support and disseminate social skills (i.e. positive parenting, conflict resolution), economic skills (i.e. entrepreneurship, farming), and health skills (i.e. ART adherence, retention in care to produce viral suppression). The overall outcome is improved social, health, and economic well-being.

Eligibility

Inclusion Criteria:

Criteria for inclusion of subjects include:

  • testing positive for HIV, confirmed by the Ministry of Health clinics
  • being at or older than 13 years of age
  • initiating care at a qualified Ministry of Health clinic in the catchment area, or intending to initiate care at such a clinic (see below for definition)
  • Any gender, age (13+ years), and comorbid disease states
  • Provide informed consent if adult, emancipated minor or mature minor
  • Provide assent if minor with guardian, who must provide informed consent

Qualified clinical locations include

  • those with accessible and usable public land to convene weekly meetings,
  • no current program targeting families with HIV known to the Ministry of Health

Exclusion Criteria:

  • Refusal to participate
  • Current participation in a similar program
  • Residing in a location with a similar program targeting patients with HIV
  • Not covered by inclusion criteria.

Study details

ART, Hiv, Trust, Depression, Anxiety

NCT04588883

The University of Texas Medical Branch, Galveston

26 January 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.